SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-006563
Filing Date
2019-11-29
Accepted
2019-11-29 15:01:47
Documents
5
Period of Report
2019-12-27
Effectiveness Date
2019-11-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2240169zdef14a.htm DEF 14A 582395
2 G875589.JPG g875589.jpg GRAPHIC 9294
3 G561611.JPG g561611.jpg GRAPHIC 24049
4 G122382.JPG g122382.jpg GRAPHIC 69934
5 G231002BGI001.JPG g231002bgi001.jpg GRAPHIC 1461
  Complete submission text file 0001047469-19-006563.txt   728330
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37686 | Film No.: 191261036
SIC: 2834 Pharmaceutical Preparations